January 25, 2022

Volume XII, Number 25

Advertisement
Advertisement

January 24, 2022

Subscribe to Latest Legal News and Analysis

Diagnosing Health Care - No Surprises Act: Considerations for Plans and Providers [PODCAST]

In this episode of the Diagnosing Health Care Podcast:  On December 27, 2020, President Trump signed into law the No Surprises Act as part of the $2.3 billion Consolidated Appropriations Act. Recently, the Biden administration issued its first interim final rule in order to implement this act, which will go into effect on January 1, 2022. While the goal is to protect patients from surprise billing, the law will also impose significant compliance burdens on plans, providers, and facilities.

Epstein Becker Green attorneys Helaine FingoldBob Hearn, and Alexis Boaz discuss the key areas health care companies need to keep in mind as they prepare to comply with the No Surprises Act.

The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces. Subscribe on your favorite podcast platform.

 

©2022 Epstein Becker & Green, P.C. All rights reserved.National Law Review, Volume XI, Number 273
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Helaine I. Fingold, Epstein Becker Green, Health Care, life sciences
Senior Counsel

HELAINE I. FINGOLD is a Senior Counsel in the Health Care and Life Sciences practice, in the Baltimore office of Epstein Becker Green. She has more than 20 years of broad health law and regulatory experience, including prior government experience in both the legislative and executive branches of the federal government.

Ms. Fingold:

Advises on issues involving the Medicare Program Parts A, B, C, and D, Medicare Innovations, Medicare Dual Eligibles, Medicaid, and Veterans' health care programs

...

443-663-1354
Member of the Firm

Bob Hearn believes in making legal work count and never losing sight of every task’s value proposition. He uses creative but practical strategies to resolve disputes, manage liabilities, and untangle regulatory and compliance challenges in an efficient yet durable manner. That’s why clients trust him when complex and potentially costly matters require attention.

Bob’s practice, while legally diverse—covering both litigation and regulatory, compliance, and business counseling work—has a strong focus on the health care and life science sector. Bob has dedicated a significant part of...

727-346-3767
Alexis Boaz Health Care & Life Sciences Attorney Epstein Becker & Green Washington, DC
Associate

Alexis Boaz is an Associate in the Health Care and Life Sciences practice, in the Washington, DC, office of Epstein Becker Green. She will be focusing her practice on fraud and abuse, transactional, regulatory, and compliance matters.

Ms. Boaz received her Juris Doctor from The George Washington University Law School (“GW”), where she was a student attorney for the Health Insurance Counseling Project and a recipient of the President’s Volunteer Service Award and GW Excellence in Service Award in recognition of her pro bono work. She also earned a Master of Public Health in Health...

202-861-1889
Advertisement
Advertisement
Advertisement